The O-GlcNAc modification promotes terminal differentiation of human corneal epithelial cells
Authors:
- Ashley M WoodwardAWAshley M Woodward
- Damien GuindoletDGDamien Guindolet
- Pablo ArgüesoPablo Argüeso
- 13 April 2020
- journal article
- conference paper
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 30 (11) , 872-880
Abstract
Dynamic modification of nuclear and cytoplasmic proteins with O-linked β-N-acetylglucosamine (O-GlcNAc) plays an important role in orchestrating the transcriptional activity of eukaryotic cells. Here, we report that the O-GlcNAc modification contributes to maintaining ocular surface epithelial homeostasis by promoting mucin biosynthesis and barrier function. We found that induction of human corneal epithelial cell differentiation stimulated the global transfer of O-GlcNAc to both nuclear and cytosolic proteins. Inflammatory conditions, on the other hand, were associated with a reduction in the expression of O-GlcNAc transferase at the ocular surface epithelia. Loss- and gain-of-function studies using small interfering RNA targeting O-GlcNAc transferase, or Thiamet G, a selective inhibitor of O-GlcNAc hydrolase, respectively, revealed that the presence of O-GlcNAc was necessary to promote glycocalyx barrier function. Moreover, we found that Thiamet G triggered a correlative increase in both surface expression of MUC16 and apical epithelial cell area while reducing paracellular permeability. Collectively, these results identify intracellular protein O-glycosylation as a novel pathway responsible for promoting the terminal differentiation of human corneal epithelial cells.Keywords
Funding Information
- National Institutes of Health (P30EY003790, R01EY026147)
This publication has 41 references indexed in Scilit:
- The ocular surface epithelial barrier and other mechanisms of mucosal protectionCurrent Opinion in Allergy and Clinical Immunology, 2013
- TNF-α–mediated bronchial barrier disruption and regulation by src-family kinase activationJournal of Allergy and Clinical Immunology, 2013
- Targeted Disruption of Core 1 β1,3-galactosyltransferase (C1galt1) Induces Apical Endocytic Trafficking in Human Corneal KeratinocytesPLOS ONE, 2012
- Assessing Mucin Expression and Function in Human Ocular Surface Epithelia In Vivo and In Vitro2011
- Notch Signaling Modulates MUC16 Biosynthesis in an In Vitro Model of Human Corneal and Conjunctival Epithelial Cell DifferentiationInvestigative Ophthalmology & Visual Science, 2011
- Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial BarrierJournal of Biological Chemistry, 2009
- Glycogene Expression in Conjunctiva of Patients with Dry Eye: Downregulation of Notch SignalingInvestigative Ophthalmology & Visual Science, 2009
- A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivoNature Chemical Biology, 2008
- Interleukin-6 and Tumor Necrosis Factor-α Levels in Tears of Patients With Dry Eye SyndromeCornea, 2007
- MUC16 Mucin Is Expressed by the Human Ocular Surface Epithelia and Carries the H185 Carbohydrate EpitopeInvestigative Ophthalmology & Visual Science, 2003